Having invested about $200m in a series of deals, Small Bone Innovations (SBI) sells shoulder unit to Fx Solutions.

Morgan Stanley owns 20.8% of Sagent and will co-lead its flotation.

Eight institutional shareholders hold more than 5% of Fluidigm ahead of its Nasdaq flotation.

PhaseBio said the second slice of $15m from the B round followed the completion of drug milestones.

Although Transave's corporate and venture capital backers will own a minority, 46.7%, stake in the combined business with Insmed, its staff will take the senior jobs.

Series E round for healthcare company Adimab at a pre-money valuation of $520m, according to news provider Xconomy.

Fenwick & West's Third Quarter 2010 Silicon Valley Venture Capital Survey of 107 deals found more than half showed an increase in price per share compared to previous financing rounds.

Mitra Biotech raises $1.1m for cancer research.